HCA Healthcare, Inc. - HCA STOCK NEWS

HCA Healthcare reported its second quarter financial results for 2022, with revenues of $14.820 billion, up from $14.435 billion in 2021. Net income was $1.155 billion, or $3.90 per diluted share, down from $1.450 billion, or $4.36 per diluted share in 2021. Adjusted EBITDA fell to $3.042 billion from $3.219 billion a year earlier. Same facility admissions dipped 1.2%, although emergency room visits rose by 7.3%. The company announced a quarterly cash dividend of $0.56 per share, payable on September 30, 2022.

HCA Healthcare, Inc. (NYSE: HCA) will host its 2Q Earnings Release Call on July 22, 2022, at 8:00 AM Central (9:00 AM Eastern). Investors can listen live via audio on the internet. The event can be accessed through the HCA Healthcare investor relations page. An archived version of the call will also be available for those unable to attend live. This call is expected to provide insights into HCA's quarterly performance, including earnings and operational updates.

McKesson Corporation and HCA Healthcare have announced a joint venture to combine their oncology research arms, US Oncology Research and Sarah Cannon Research Institute, enhancing clinical trial access and drug development. This venture aims to expand oncology research, streamline trial matching for patients, and improve access, particularly for underserved communities. McKesson will hold 51% ownership, with the joint venture expected to close in 2022. Financial details remain undisclosed, and the agreement is subject to regulatory approvals.

McKesson Corporation and HCA Healthcare have announced a joint venture to combine their oncology research efforts, enhancing clinical trials and treatment options for cancer patients. The venture will merge McKesson’s US Oncology Research with HCA’s Sarah Cannon Research Institute, aiming to improve access and accelerate cancer drug development, especially in underserved communities. McKesson will hold a 51% stake and operating control. The deal is expected to close in 2022, pending regulatory approval and customary conditions.

HCA Healthcare announced the opening of a new Galen College of Nursing campus in Asheville, North Carolina, enhancing nursing education amid a national shortage. The new campus, opening in late September, will be the eighth location for Galen since joining HCA in 2020, expanding total enrollment to approximately 10,000 students. The U.S. Bureau of Labor Statistics projects 194,500 annual nursing job openings for the next decade, highlighting the growing need for trained nurses. HCA aims to leverage this partnership to improve patient care and nursing education.

HCA Healthcare has announced a three-year, $1.38 million grant to the Girl Scouts of the USA for youth mental wellness workshops. This initiative aims to develop curricula focusing on mental health for girls in grades 4-12, with workshops launching in summer 2023. The grant is part of the Healthier Tomorrow Fund, which has committed $4.5 million since 2021 to address community health needs. HCA Healthcare emphasizes the importance of mental health, supporting various initiatives including the Nurse Care program for caregivers.

HCA Healthcare has appointed Keith Zimmerman as the new president of its MidAmerica Division, effective June 13, following the retirement of Mel Lagarde. Zimmerman, a 31-year healthcare veteran and former CEO of Medical City Arlington, will oversee seven hospitals and various care sites in the Kansas City area. During Lagarde's 40-year tenure, he contributed significantly to HCA's success. HCA operates 182 hospitals and approximately 2,300 ambulatory sites, emphasizing patient-focused care and clinical advancements.

HCA Healthcare (NYSE: HCA) is scheduled to present at two healthcare conferences in May 2022. The first presentation will be on May 11, 2022, at 8:00 am PDT during the BofA Securities 2022 Healthcare Conference in Las Vegas, NV. The second presentation is set for May 18, 2022, at 9:30 am EDT, at the RBC Capital Markets Global Healthcare Conference in New York, NY. Investors can access live audio webcasts and presentation materials on the company’s website, with details subject to change.

Valify, a healthcare cost management company based in Frisco, Texas, has been named “Company of the Year” by CIOReview in the 50 most promising healthcare solutions category. Valify utilizes a proprietary technology platform to analyze healthcare spending, helping hospitals reduce operational costs and financial risk. The company, acquired by HCA Healthcare, manages over $600 billion in categorized spend across 1,300 service categories, offering end-to-end cost management solutions to thousands of hospitals.